165
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo

, , , , &
Pages 272-280 | Received 06 Oct 2011, Accepted 26 Nov 2011, Published online: 28 Dec 2011

References

  • Abdou S, Collomb J, Sallas F, Marsura A, Finance C. (1997). β-Cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence. Arch Virol, 142, 1585–1602.
  • Anno T, Motoyama K, Higashi T, Hirayama F, Uekama K, Arima H. (2011). Preparation and evaluation of polyamidoamine dendrimer (G2)/branched-β-cyclodextrin conjugate as a novel gene transfer carrier. J Incl Phenom Macrocycl Chem, 70, 339–344.
  • Arima H, Kihara F, Hirayama F, Uekama K. (2001). Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins. Bioconjug Chem, 12, 476–484.
  • Arima H, Motoyama K. (2009). Recent findings concerning PAMAM dendrimer conjugates with cyclodextrins as carriers of DNA and RNA. Sensors, 9, 6346–6361.
  • Arima H, Yamashita S, Mori Y, Hayashi Y, Motoyama K, Hattori K, Takeuchi T, Jono H, Ando Y, Hirayama F, Uekama K. (2010). In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/α-cyclodextrin conjugates (G2) into hepatocytes. J Control Release, 146, 106–117.
  • Avall-Lundqvist E, Economidou-Karaoglou A, Sjövall K, Lans M, Taper HS, Roberfroid M, Eneroth P. (1989). Serum alkaline DNase activity in normal or nonhospitalised individuals. Clin Chim Acta, 185, 35–43.
  • Banerjee P, Weissleder R, Bogdanov A Jr. (2006). Linear polyethyleneimine grafted to a hyperbranched poly(ethylene glycol)-like core: a copolymer for gene delivery. Bioconjug Chem, 17, 125–131.
  • Bellocq NC, Pun SH, Jensen GS, Davis ME. (2003). Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem, 14, 1122–1132.
  • Bender M, Komiyama M. (1978). Cyclodextrin chemistry, Berlin: Springer-Velag.
  • Bielinska A, Kukowska-Latallo JF, Johnson J, Tomalia DA, Baker JR Jr. (1996). Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res, 24, 2176–2182.
  • Croyle MA, Roessler BJ, Hsu CP, Sun R, Amidon GL. (1998). β cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharm Res, 15, 1348–1355.
  • Feinberg H, Park-Snyder S, Kolatkar AR, Heise CT, Taylor ME, Weis WI. (2000). Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor. J Biol Chem, 275, 21539–21548.
  • Felgner PL, Barenholz Y, Behr JP, Cheng SH, Cullis P, Huang L, Jessee JA, Seymour L, Szoka F, Thierry AR, Wagner E, Wu G. (1997). Nomenclature for synthetic gene delivery systems. Hum Gene Ther, 8, 511–512.
  • Freeman DJ, Niven RW. (1996). The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs. Pharm Res, 13, 202–209.
  • Gabrielson NP, Pack DW. (2006). Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules, 7, 2427–2435.
  • Huang H, Tang G, Wang Q, Li D, Shen F, Zhou J, Yu H. (2006). Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-β-cyclodextrin or (2-hydroxypropyl)-γ-cyclodextrin. Chem Commun (Camb), 2382–2384.
  • Ilangumaran S, Hoessli DC. (1998). Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J, 335 (Pt 2), 433–440.
  • Irie T, Uekama K. (1997). Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci, 86, 147–162.
  • Irie T, Uekama K. (1999). Cyclodextrins in peptide and protein delivery. Adv Drug Deliv Rev, 36, 101–123.
  • Isaka Y. (2006). Gene therapy targeting kidney diseases: routes and vehicles. Clin Exp Nephrol, 10, 229–235.
  • Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. (2002). Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin. Bioconjug Chem, 13, 1211–1219.
  • Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. (2003). In vitro and in vivo gene transfer by an optimized α-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug Chem, 14, 342–350.
  • Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR Jr. (1996). Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA, 93, 4897–4902.
  • Ledley FD. (1995). Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther, 6, 1129–1144.
  • Luo D, Saltzman WM. (2000). Synthetic DNA delivery systems. Nat Biotechnol, 18, 33–37.
  • Ma H, Diamond SL. (2001). Nonviral gene therapy and its delivery systems. Curr Pharm Biotechnol, 2, 1–17.
  • Marttin E, Verhoef JC, Merkus FW. (1998). Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J Drug Target, 6, 17–36.
  • Monsigny M, Rondanino C, Duverger E, Fajac I, Roche AC. (2004). Glyco-dependent nuclear import of glycoproteins, glycoplexes and glycosylated plasmids. Biochim Biophys Acta, 1673, 94–103.
  • Park MR, Han KO, Han IK, Cho MH, Nah JW, Choi YJ, Cho CS. (2005). Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release, 105, 367–380.
  • Qin L, Pahud DR, Ding Y, Bielinska AU, Kukowska-Latallo JF, Baker JR Jr, Bromberg JS. (1998). Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. Hum Gene Ther, 9, 553–560.
  • Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K. (1999). Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell, 10, 961–974.
  • Rolland AP. (1998). From genes to gene medicines: recent advances in nonviral gene delivery. Crit Rev Ther Drug Carrier Syst, 15, 143–198.
  • Saenger W. (1980). Cyclodextrin inclusion compounds in research and industry. Angew Chem Int Ed Engl, 19, 344–362.
  • Sternberg PW, Schmid SL. (1999). Caveolin, cholesterol and Ras signalling. Nat Cell Biol, 1, E35–E37.
  • Subramanian A, Ranganathan P, Diamond SL. (1999). Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat Biotechnol, 17, 873–877.
  • Szejtli J. (1988). Cyclodextrin technology. Dordrecht, The Netherlands: Kluwer.
  • Tomalia DA, Naylor AM, Goddard WA. (1990). Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl, 29, 138–175.
  • Uekama K, Hirayama F, Irie T. (1998). Cyclodextrin Drug Carrier Systems. Chem Rev, 98, 2045–2076.
  • Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F, Uekama K. (2005a). Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates. J Control Release, 104, 397–413.
  • Wada K, Arima H, Tsutsumi T, Hirayama F, Uekama K. (2005b). Enhancing effects of galactosylated dendrimer/α-cyclodextrin conjugates on gene transfer efficiency. Biol Pharm Bull, 28, 500–505.
  • Zhao Q, Temsamani J, Agrawal S. (1995). Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery. Antisense Res Dev, 5, 185–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.